Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
3.400
+0.060 (1.80%)
At close: Oct 30, 2026, 4:00 PM EDT
3.500
+0.100 (2.94%)
After-hours: Oct 30, 2026, 7:41 PM EDT
Intensity Therapeutics Employees
As of December 31, 2025, Intensity Therapeutics had 7 total employees, including 5 full-time and 2 part-time employees. The number of employees did not change compared to the previous year. That makes Intensity Therapeutics the 41,122nd largest employer in the world and 6,273rd in the United States.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,594,714
Market Cap
11.10M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | 0 | - | 5 | 2 |
| Dec 31, 2024 | 7 | 0 | - | 5 | 2 |
| Dec 31, 2023 | 7 | 3 | 75.00% | 5 | 2 |
| Mar 31, 2023 | 4 | -2 | -33.33% | 3 | 1 |
| Jun 30, 2022 | 4 | - | - | 4 | 0 |
| Mar 31, 2022 | 6 | - | - | 5 | 1 |
| Dec 31, 2021 | 6 | - | - | 5 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 138 |
| aTyr Pharma | 60 |
| CytoMed Therapeutics | 42 |
| Passage Bio | 24 |
| SeaStar Medical Holding | 18 |
| Lipocine | 14 |
| BioVie | 13 |
| Tvardi Therapeutics | 12 |
INTS News
- 1 day ago - Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026 - PRNewsWire
- 8 days ago - Intensity reports data from Cohort A in the INVINCIBLE-4 Study - TheFly
- 8 days ago - Intensity Therapeutics, Inc. to Present INVINCIBLE-4 Neoadjuvant Triple-Negative Breast Cancer Study Data for the First Seven (7) Patients After INT230-6 Treatment (Cohort A) in an ePoster Presentation at the European Society of Medical Oncology (ESMO) Meeting - PRNewsWire
- 7 weeks ago - Intensity Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 7 weeks ago - Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - PRNewsWire
- 2 months ago - Intensity Therapeutics price target raised to $7 from $5 at H.C. Wainwright - TheFly
- 2 months ago - Intensity Therapeutics price target lowered to $15 from $30 at Alliance Global - TheFly
- 2 months ago - Intensity Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts